Atlas Trials

Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease

Clinical trial NCT05758766 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05758766
Sponsor
University of Alabama at Birmingham
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2023-08-30
Primary completion
2026-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.